Hybrigenics to Perform Protein Interaction Mapping for OGS | GenomeWeb

NEW YORK, July 23 – Oxford Glycosciences and Hybrigenics have entered into a collaboration to study OGS’ protein drug targets, the companies said Monday.

The arrangement calls for Paris-based Hybrigenics to identify how a selected number of protein targets associated with cancer and neurological disorders interact with Hybrigenic’s library of proteins. The results will help OGS prioritize its existing drug targets and could potentially uncover new proteins with potential as drug targets, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."